Search - tctmd.com

Displaying 641 - 660 of 891

Sort: Relevancy | Date

Presentation TCT 2015

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Deepak L. Bhatt

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Presenter: William A. Gray, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

A Trial of Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Pascal Vranckx, Renato D. Lopes

October 14, 2015

Presentation TCT 2015

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Presenter: Pascal Vranckx, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Reversal Agents for Factor Xa Inhibitors

Presenter: Lisa K. Jennings, Matthew T. Roe

October 14, 2015

Presentation TCT 2015

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe, Manesh R. Patel

October 14, 2015

Presentation TCT 2015

Apixaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe

October 14, 2015

Presentation TCT 2015

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

Presenter: Lisa K. Jennings, Matthew T. Roe, Pascal Vranckx

October 14, 2015

News Conference News TCT 2015

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

October 14, 2015

News Conference News TCT 2015

PFO Closure Still Attracts Controversy

Yael L. Maxwell

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Presentation TCT 2015

TCT 33: Left Atrial Decompression With the V-Wave Shunt Device for the Treatment of Heart Failure Preliminary Safety and Efficacy Results

Presenter: John P. Cheatham, Carlos Pedra, Maria Del Trigo

October 13, 2015

Presentation TCT 2015

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

Presenter: Eric A. Cohen, Truls Råmunddal, Ching-Chang Huang

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

Presentation TCT 2015

Acute DAPT Decisions: Agent Selection and Whether to Load

Presenter: George D. Dangas, Paul A. Gurbel

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Linnemeier Young Investigator Award Goes to Toby Rogers, BM BCh

October 13, 2015

Advertisement

The RE-DUAL PCI Trial (Dabigatran in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

A Trial of Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Reversal Agents for Factor Xa Inhibitors

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Apixaban: Analysis of Efficacy, Safety, and Special Considerations

Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents)

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

PFO Closure Still Attracts Controversy

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

TCT 33: Left Atrial Decompression With the V-Wave Shunt Device for the Treatment of Heart Failure Preliminary Safety and Efficacy Results

TCT 24: Selection of Collateral Channel Guided by a Hierarchic Decision Algorithm Achieved High Technical Success Rate and Low Procedural Complication Rate in Real-world Retrograde Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO)

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Acute DAPT Decisions: Agent Selection and Whether to Load

Trial Results Often Struggle to Keep Pace With Evolving Technology

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Linnemeier Young Investigator Award Goes to Toby Rogers, BM BCh

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content